|
KR20010053355A
|
|
A process for the monosodium tri-hydrate of 4-amino-1-hydroxybutylidene -1,1-diphosphonic acid
|
|
KR20010037885A
|
|
Pharmaceutical compositions and preparations for treatment of metabolic bone disease
|
|
CN1352564A
|
|
Pharmaceutical composition containing elegiline and ginkgo bioloba extract useful for dementia
|
|
KR20000066775A
|
|
Pharmaceutical compositions containing selegiline and ginkgo biloba extract useful for dementia
|
|
KR20000061388A
|
|
process for the 4-amino-1-hydroxybutylidene -1,1-diphosphonic acid and its salt
|
|
KR20000050855A
|
|
Injection containing high concentrated Aesculus Hippocastanum extract for remedy inflammatory and method of manufacturing the same material
|
|
KR100258018B1
|
|
A pharmaceutical composition comprising ticlopidine and ginkgo extract
|
|
KR960010622B1
|
|
Method of extraction and purification for active substances from ginko herb
|
